tbuckley/cabot-search huggingface dataset:
Cancer risk of pesticides in agricultural workers. Council on Scientific Affairs
Journal: JAMA (1988)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Clinically important radiation-associated thyroid disease. A controlled study
Authors: H. R. Maxon
Journal: JAMA (1980)

We evaluated 1,266 persons who had received external radiotherapy for benign diseases in childhood. The evaluation used detailed questionnaires completed by trained interviewers and neoplastic disease registry data. The control population included 958 age-, sex-, race-, and diseasematched persons who had not received radiotherapy and 9,865 family members of the two study groups. An excess number of clinically important thyroid neoplasms, both benign and malignant, was noted in the irradiated group. (<i>JAMA</i>244:1802-1805, 1980)
Advances in hepatic encephalopathy and metabolic nitrogen exchange Edited by Livio Capocaccia, Manuela Merli, and Oliviero Riggio, 630 pp. Boca Raton: CRC Press, 1995. $199.95
Authors: A BLEI
Journal: Hepatology (1995)

L'étude comparative détaillée des séries carbonatées d'âge Crétacé inférieur (Valanginien à Aptien inférieur p.p.) de Provence et de Sardaigne: Basse-Provence méridionale et Sardaigne occidentale d'une part, Basse-Provence septentrionale et Sardaigne orientale de l'autre, montre les analogies stratigraphiques (litho- et biostratigraphiques) entre ces deux ensembles. L'Hauterivien calcaire, dont la présence avait été localement ignorée ou l'importance sous-estimée, est caractérisé en différents secteurs de la Sardaigne. On apporte de nouveaux éléments concernant les analogies paléobiogéographiques entre cette région et la Provence (Rudistes et algues) et l'on souligne l'absence d'éléments caractéristiques du domaine italo-yougoslave, notamment en Sardaigne orientale.Dans l'hypothèse de la dérive du bloc corso-sarde, on effectue la comparaison de la zonéographie des plates-formes sarde et provençale. Il apparaît ainsi que, suivant la transversale: Monts de Vaucluse, Marseille, Toulon, Capo Caccia et Orosei, l'évolution des environnements dans le temps et leur migration dans l'espace présentent une remarquable symétrie par rapport à l'axe de l'actuel bassin valentino-ligure. Ces conceptions paléogéographiques ne s'accordent pas avec l'hypothèse d'une zone centrale émergée en Sardaigne durant le Crétacé inférieur. Enfin, nous proposons l'existence d'un “bassin” à l'ouest de la Sardaigne sud-occidentale, durant une partie au moins de l'Eocrétacé.The study of the Valanginian to Lower Aptian carbonates of Provence and Sardinia shows stratigraphical analogies for S Basse Provence and W Sardinia, on the one hand, with N Basse Provence and E Sardinia, on the other. A calcareous Hauterivian facies has been evaluated in Sardinia. New palaeobiogeographical data for rudists and algae are presented. The hypothesis of the drift of the Corsican-Sardinian block is applied to the interpretation of the platforms of Sardinia and Provence. The symmetrical evolution of the Valencian-Ligurian basin is demonstrated. The palaeographical conclusions arrived at do not agree with the hypothesis of a central emerged zone in Sardinia during the Early Cretaceous. The existence of a “basin” to the west of SW Sardinia is postulated for at least a part of the Early Cretaceous.
HEROIN PULMONARY EDEMA
Journal: JAMA (1968)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Pleasant memories: remembering immune protection while forgetting about graft-versus-host disease
Authors: P. M. Sondel
Journal: Journal of Clinical Investigation (2003)

Graft-versus-host disease (GVHD) represents a major cause of morbidity and mortality following conventional allogeneic hematopoietic stem cell transplantation (HSCT). A study in mice (see related article on pages 101–108) demonstrates that the selective administration of donor memory CD4+ T cells results in immune reconstitution without GVHD, a result that, if translatable to humans, has important clinical implications for HSCT.
Prognosis
Journal: JAMA (2000)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
From the NIH. Radionuclide therapy for arthritic knees
Authors: L. K. Doepel
Journal: JAMA (1985)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
BOOK REVIEWS
Authors: E. S. ZINREICH
Journal: JNCI Journal of the National Cancer Institute (1992)

Journal Article BOOK REVIEWS Get access Levitt and Tapley's Technological Basis of Radiation Therapy: Practical Clinical Applications, 2nd Edition Seymour H. Levitt , Faiz M. Khan , Roger A. Potish , eds. Philadelphia : Lea & Febiger , 1992 . 414 pp., illus. $75 EVA S. ZINREICH, M.D. EVA S. ZINREICH, M.D. 10 Stream Cr. Owings Mills. MD 21117 Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 84, Issue 17, 2 September 1992, Page 1360, https://doi.org/10.1093/jnci/84.17.1360 Published: 02 September 1992
Re: Stephen B. Williams, Marcus G.K. Cumberbatch, Ashish M. Kamat, et al. Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.06.039
Authors: Gianluca Giannarini, Vincenzo Ficarra, Claudio Valotto
Journal: European Urology (2020)
American Review of Respiratory Diseases, New York
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
IMMUNIZATION AGAINST PLAGUE: EXPERIENCE OF A MEDICAL MISSIONARY WITH HAFFKINE'S VACCINE
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Physician reporting of aircraft pilot impairments
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
BERLIN
Journal: JAMA (1929)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Ligue Europeenne contre le Rhumatisme: Report of the Secretary General, August 23, 1953
Journal: Annals of the Rheumatic Diseases (1953)

library, he can pick up a 414-page volume by Coste, Cayla, and Delbarre on "Cortisone et Corticostimuline (ACTH) en Rhumatologie", or Copeman's "Cortisone and ACTH in Clinical Practice".At the same time one can sympathize with the editors in their attempt to keep the work within reasonable bounds.The print is good and the quality of the paper, though not uniform, is satisfactory.Each disease is introduced by a short and informative historical survey which stimulates interest.Bibliographical references are usually indicated by a number in the text and a footnote, but too frequently the reader is left to make what he can of a string of names only.Thus, when describing sacraliza- tion of L5, one reads that "c'est depuis 1910, en effet, que Adams, Goldwait, Kleinschmidt ont etudie les consequences clinique de la malformation.A leur suite, et apres les observations de Denuce, Calve, Japiot ... " (p.208).This work will, of course, have a limited appeal, but the magnitude of the task undertaken is so great that the editors and publishers can take justifiable pride in their achievement.DAVID PREISKEL.some of the previous volumes and an index of 240 pages replete with eponymous diseases and illustrious names (that of Heberden being, however, unfortunately omitted).The publishers claim that this volume completes "l'ouvrage le plus important et le plus riche de substance qui ait ete publie au cours des trois derni6res annees"; it is also claimed that each volume is so arranged that it can be bought and used separately as a monograph, but the presence of the index and important addenda in the last volume tends to emphasize the unity of the series.As a work of reference, for which it is primarily intended, this compilation suffers from a number of faults which, no doubt, will be rectified in later editions.Fanconi's syndrome, for instance, is not described in this volume, but the index tells us that it is to be found in Vol.XII (devoted to blood diseases); similarly, osteomyelitis is placed in Vol.I (infectious diseases), and scleroderma in Vol.XIII (diseases of endocrine glands).Neither disseminated lupus erythematosus nor osteoid osteoma is described in Vol.XVII, and neither can be traced in the index.Four pages are devoted to cortisone and ACTH; these, though adequate for a text-book, will hardly satisfy a French rheumatologist, when, in the same
Long term relative survival (RS) in patients with primary metastatic kidney cancer: An analysis of 2,167 patients from the Austrian National Cancer Registry (ANCR).
Authors: Martin Marszalek, Henrike E Karim-Kos, Stephan Madersbacher, Monika Hackl, Michael Rauchenwald
Journal: Journal of Clinical Oncology (2019)

e16069 Background: The introduction of thyrosinkinase inhibitors (TKI) changed the treatment of metastatic kidney cancer fundamentally. In Austria, TKI was in troduced in 2006. To elaborate the potential impact of TKI therapies, we studied trends in OS for patients diagnosed with primary metastatic kidney cancer between1998 and 2015 in Austria. Methods: All patients with primary metastatic kidney cancer aged ≥18 years, diagnosed from 1998-2015 were derived from the ANCR (n = 2,490). Patients diagnosed from 2004-2005 (n = 323) were excluded (transition period of systemic therapies). To evaluate survival differences between patients treated before and after the introduction of Sunitinib (preTKI-era and TKI-era), three periods were defined: 1998-2003 (preTKI-era; N = 937), 2006-2010 (TKI-era P1; N = 687) and 2011-2015 (TKI-era P2; N = 543). Follow-up was complete until December 31st, 2016. RS rates were estimated by using method. The Cox proportional hazard model was used to calculate hazard ratios (HR). Results: A total of 2,167 patients was included in the analysis. The median age of the study population was 70 yrs and did not differ between the three eras. The incidence of T1 tumors increased from 6.9% in the preTKI-era to 10% in the TKI-era while T4 tumors decreased from 15% to 8% (p &lt; .001). Surgery rate declined from 50% in the preTKI-era to 43% in 2011-2015 (p = .02). Five-year RS for patients undergoing surgery slightly increased from 18% in the preTKI-era to 23% in TKI-era P1 (p = .04). For patients without (p = .04). For patients without surgery 5-year OS improved from 5.2% in the preTKI-era to 9.1% in TKI-era P1 (p &lt; .001). Apart from surgery, survival gain was observed for younger patients ( &lt; 75 yrs) of +6% (p = .01), older patients ( &gt; = 75 years) of +0.2% (p = .03) and for T3/T4 tumors of +6% (p = .002). The Relative Excess Risk of dying (RER) for patients treated in the TKI-eras was reduced compared to the preTKI-era (HR 0.78, 95% CI 0.76-0.95) adjusted for sex, age, T-stage and surgery. Survival advantage for patients undergoing surgery remained significant (HR: 0.46, 95% CI 0.41-0.52) after adjustment for TKI-era, sex, age, T-stage. Conclusions: Patients with primary metastatic kidney cancer treated in the TKI era show improved RS compared to the cytokine era. Most benefit was observed in non-surgical patients, younger patients and for T3/T4 disease. Surgery remains as an important therapy for additional survival benefit.
Randomized, open-label trial of gemcitabine/nab-paclitaxel (G/NP) ±FG-3019 as neoadjuvant chemotherapy in locally advanced, unresectable pancreatic cancer (LAPC).
Authors: Vincent J. Picozzi, Flavio G. Rocha, Scott Helton, Kabir Mody, Horacio Asbun, Michael J. Pishvaian, Patrick G Jackson, Tina Etheridge, Mairead Carney, Thomas B Neff, Seth Porter, Gerald Crans, Frank Valone, Wen Shi
Journal: Journal of Clinical Oncology (2016)

457 Background: Curative therapy for PDAC is currently achievable through resection only, but ≤ 15% of patients are candidates for surgery. FG-3019, a recombinant human mAb to connective tissue growth factor (CTGF), plus gemcitabine (G) significantly reduced tumor growth, increased apoptosis and improved survival vs G alone in the KPC mouse model. Higher FG-3019 exposure and lower baseline (BL) CTGF were independently and significantly associated with improved overall median and 1-year survival (OS) in a Ph2a trial with G and erlotinib in stage 3 or 4 PDAC. Neoadjuvant treatment of LAPC with FG-3019 combined with multidrug therapy may change the fibrotic character of LAPC and thus may make it amenable to surgical resection and potentially improve OS. Methods: Patients with unresectable LAPC (confirmed by laparoscopy) are randomized to G/NP ±FG-3019 for 6-cycle/24-week treatment. Safety, efficacy, PK and changes in CT, PET, &amp; CA19.9 from BL through end of treatment (EOT) are assessed. Up to 4 endoscopic ultrasound (EUS) guided core biopsies are collected at BL. Protein microarrays of pre- and post-treatment biopsies are prepared from tumor and stromal cells isolated by laser capture microdissection. Surgical exploration is performed in subjects who achieved the protocol-defined criteria for possible resection. Results: To date, 11 subjects were enrolled with 5 randomized to +FG-3019 arm. There were no complications from laparoscopy or EUS core biopsies that were clinically significant or delayed dosing. Per investigator assessment, no FG-3019-related SAEs were reported, nor any identified toxicity suspected from combination of FG-3019 with chemotherapy. Overall, CA19.9 mean change from BL was −62.7% at Week 8 (n = 8), and target lesions were reduced by 20.6% (n = 6) at Week 16. Three out of 4 subjects had PET SUV max reductions of ≥ 30% at EOT. Additional data from protein microarrays will be presented. Conclusions: Based on the limited data collected so far, this trial design is feasible and the G/NP +FG-3019 combination is well-tolerated and appears to be active. Summary results on surgical exploration of subjects will be provided later. Clinical trial information: NCT02210559.
Septicaemia Due to Mixed Infection. A Correction
Journal: BMJ (1918)

Thle Education Committee reported that more than 12,000 children with discharging ears are in attendance at school.Some 7,000 children have easily appreciable deafness, and, in addition, 800 children attend deaf schools or "hard of hearing " classes.About 800 children of school age die in London annually fromi diseases closely associated with ear disease.
Honours List: Correction
Journal: BMJ (1952)

ANY QUESTIONS? of 100 mg.twice a day was more effective than other measures in a series of cases recently reported.The prognosis is bad in the sense that the condition destroys skin and hair and produces an irreversible, scar- ring alopecia.The disease does not affect the general health.If extensive, ulceration sometimes occurs, which generally responds to small doses of sulphonamide by mouth and locally, but this treatment must be used with care.Malig- nant changes are rarely seen.